Vaccine-Associated Aluminum Linked to Persistent Asthma in Young Children
Positive association seen for children with and without eczema; CDC is not changing current vaccine recommendations
Diagnosis & Disease Information
Guidelines Issued for Management of Pollen Food Syndrome
Management involves exclusion of known trigger foods; immunotherapy to pollens not effective for PFS
Mepolizumab Cuts Exacerbations in Children With Severe Asthma
Trial enrolled children from disadvantaged urban neighborhoods who have exacerbation-prone eosinophilic asthma
OCS-Sparing Effect of Dupilumab for Severe Asthma Maintained
Oral corticosteroid dosage reduction sustained in open-label extension study of dupilumab
Out-of-Pocket Costs for Epinephrine Auto-Injectors Examined
Cost-sharing still substantial for some using nonbranded auto-injectors, such as those enrolled in high-deductible health plans
Asthma Drug Fluticasone Fails as Potential COVID-19 Treatment
Finding from a nationwide study of 5,000 participants that continues to evaluate existing drugs to treat mild-to-moderate COVID-19
MPR Weekly Dose Podcast #124
Emergency Use authorization for Novavax vaccine; the Pfizer-BioNTech vaccine gains adolescent approval; submission for oral contraceptive to be switched to over the counter; Astepro nasal spray gets over-the-counter approval; and Dupixent shows benefits in pediatric patients with eosinophilic esophagitis.
Antihistamine Nasal Spray Astepro Allergy Now Available OTC
Astepro Allergy is the first OTC steroid-free antihistamine nasal spray for indoor and outdoor allergies.
MPR Weekly Dose Podcast #122
New nasal spray for allergic rhinitis; weight management drug indication is expanded to include teens; monkeypox vaccine access; COVID-19 antibody shelf-life extension; JUUL banned in the US.
FDA Clears Barrier-Forming Nasal Spray for Allergic Rhinitis
Bentrio is a drug-free, preservative-free, OTC nasal spray for protection against airborne allergens.
